Projects per year
Personal profile
Monash teaching commitment
HUP3011 - Human pathology: Atherosclerosis
HUP3011 - Human pathology: Vascular biology and disease
IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy
Central Clinical School Honours program "Molecular Imaging Technology"
Biography
Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Chemistry, PhD, Albert Ludwigs Universitat Freiburg (Albert Ludwig University of Freiburg)
Award Date: 1 Jun 2001
Chemistry, MSc, Albert Ludwigs Universitat Freiburg (Albert Ludwig University of Freiburg)
Award Date: 1 Apr 1997
External positions
President, Australian Society for Medical Research (ASMR)
22 Nov 2019 → …
NHMRC Senior Research Fellow, National Health and Medical Research Council (NHMRC) (Australia)
1 Jan 2019 → 31 Dec 2023
A/Prof, RMIT University
1 Mar 2014 → …
Research area keywords
- PET CT
- acute MI
- animal models of human disease
- antibodies
- arterial thrombosis
- drug delivery systems
- microbubbles
- molecular imaging
- platelets
- thrombosis
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Molecular Imaging of Cardiac Fibrosis in Atrial Fibrillation, Heart Failure and Myocardial Infarction
Niego, B., Alt, K. & Hagemeyer, C.
1/01/23 → 31/12/24
Project: Research
-
Conformation specific antibodies against unfolded von Willebrand factor
1/07/22 → 30/06/23
Project: Research
-
Near Infrared Fluorescence and Photoacoustic Imaging Facility
Egan, G., Bansal, V., Wood, B., Boyer, C., Voelcker, N., Cavalieri, F., Hagemeyer, C. & Corrie, S.
6/06/22 → 5/06/25
Project: Research
-
Self-regulated, glucose-responsive nanomaterials for smart insulin delivery
Hagemeyer, C. & Cavalieri, F.
1/01/20 → 31/12/23
Project: Research
-
-
Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting
Hashad, R., Jap, E., Casey, J. L., Ho, Y. T. C., Wright, A., Thalmann, C., Sleeman, M., Lupton, D. W., Hagemeyer, C. E., Cryle, M. J., Robert, R. & Alt, K., 21 Feb 2023, In: Chemistry - A European Journal. 29, 11, 7 p., e202202491.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Current and future strategies to monitor and manage coagulation in ECMO patients
Zeibi Shirejini, S., Carberry, J., McQuilten, Z. K., Burrell, A. J. C., Gregory, S. D. & Hagemeyer, C. E., Dec 2023, In: Thrombosis Journal. 21, 1, 20 p., 11.Research output: Contribution to journal › Review Article › Other › peer-review
Open Access -
18F Site‐Specific Labelling of a Single‐Chain Antibody against Activated Platelets for the Detection of Acute Thrombosis in Positron Emission Tomography
Ardipradja, K. S., Wichmann, C. W., Hickson, K., Rigopoulos, A., Alt, K. M., Pearce, H. A., Wang, X., O’keefe, G., Scott, A. M., Peter, K., Hagemeyer, C. E. & Ackermann, U., 1 Jul 2022, In: International Journal of Molecular Sciences. 23, 13, 16 p., 6886.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
A novel ex vivo approach for measuring plasminogen activation upon established plasma clots
Palazzolo, J. S., Medcalf, R. L., Hagemeyer, C. E. & Niego, B., Jul 2022, In: Research and Practice in Thrombosis and Haemostasis. 6, 5, 7 p., RTH212771.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Assessment of the epi-pericardial fibrotic substrate by collagen-targeted probes
Ezeani, M., Noor, A., Donnelly, P. S., Niego, B. & Hagemeyer, C. E., 5 Apr 2022, In: Scientific Reports. 12, 1, 12 p., 5702.Research output: Contribution to journal › Article › Research › peer-review
Open Access
-
Biochemistry & Molecular Biology (Organisational unit)
Ruby Law (Inventor), James Whisstock (Inventor), Adam Quek (Contributor), Christoph Hagemeyer (Contributor), Mikael Martino (Contributor), Jason Wu (Contributor) & Angel Lu (Contributor)
2022Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent (Provisional)
-
Cardiovascular Therapeutics (Journal)
Christoph Hagemeyer (Associate editor)
2014 → …Activity: Publication peer-review and editorial work types › Editorial responsibility
-
PLoS ONE (Journal)
Christoph Hagemeyer (Associate editor)
2013 → …Activity: Publication peer-review and editorial work types › Editorial responsibility
Equipment
-
Biomedical Imaging (MBI)
Kylie Reid (Manager), Robert Brkljaca (Manager), Christoph Hagemeyer (Other) & David Wright (Other)
Office of the Vice-Provost (Research and Research Infrastructure)Facility/equipment: Facility